Empaveli 1080 MG

Ended Awarded

Contract number
36C24524N0613
Awardee
Awarding agency
Obligated
$25,831

Award facts

Contract value 100% obligated
$25,831.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Pittsburgh, PA 15275, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order contract to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc., to provide the drug EMPAVELI to VA medical facilities in Pittsburgh, Pennsylvania. The $25,831.04 contract under the VA's Federal Supply Schedule 61-IB Pharmaceuticals and Drugs contract vehicle has a completion date of May 24, 2024. EMPAVELI is used to treat paroxysmal nocturnal hemoglobinuria, a rare blood disorder, and the short 1-2 week delivery orders are issued by the VHA's Veterans Integrated Service Network 5 to meet urgent pharmaceutical needs for veterans. In addition to this delivery order, APL Sales I LLC holds a $2 million Blanket Purchase Agreement with the VA National Acquisition Center for the drug Empagliflozin to treat diabetes. These contract vehicles allow the company to directly supply critical medications supporting the VA's healthcare services for veterans nationwide.

Quick answers

Who was awarded contract 36C24524N0613?

36C24524N0613 was awarded to APL Sales I LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on May 21, 2024.

How much is contract 36C24524N0613 worth?

The government has obligated $25,831 on 36C24524N0613.

Is contract 36C24524N0613 an order under another contract?

Yes. 36C24524N0613 is a delivery order under 36F79722D0039, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24524N0613 competed?

The extent of competition for 36C24524N0613 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award